These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30377995)

  • 1. Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection.
    Zhou J; Liu Z; Chen M; Luo ZH; Li YQ; Qi GY; Liu T
    Diabetes Ther; 2018 Dec; 9(6):2393-2398. PubMed ID: 30377995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.
    Zhang X; Wu J; Wu C; Bian AL; Geng S; Dai RP
    Diabetes Res Clin Pract; 2020 Apr; 162():108083. PubMed ID: 32057965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
    Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
    BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy.
    Zhang Y; Gao Z; Zhang X; Yuan Z; Ma T; Li G; Gao X
    Exp Ther Med; 2021 Apr; 21(4):332. PubMed ID: 33732305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor/connective tissue growth factor and proteomic analysis of aqueous humor after intravitreal conbercept for proliferative diabetes retinopathy.
    Li HS; Lyu X; Rong A; Bi YL; Xu W; Cui HP
    Int J Ophthalmol; 2024; 17(10):1816-1827. PubMed ID: 39430009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.
    Cui W; Sun XY; Sun LP; Li J; Liu ZL; Zhang H
    J Ocul Pharmacol Ther; 2021; 37(1):52-59. PubMed ID: 33216685
    [No Abstract]   [Full Text] [Related]  

  • 8. A Study on the Drug Concentration in Fellow Eyes After Unilateral Intravitreal Injection of Conbercept Into New Zealand Rabbit Eyes.
    Di Y; Xu H; Ye J; Guo Z
    Front Pharmacol; 2021; 12():783057. PubMed ID: 34925038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy.
    Huang Z; Chen LJ; Huang D; Yi J; Chen Z; Lin P; Wang Y; Zheng J; Chen W
    J Diabetes Res; 2024; 2024():2550367. PubMed ID: 39308630
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
    Li S; Yang Y; Zou J; Zeng J; Ding C
    BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
    Zhou M; Wang J; Wang W; Huang W; Ding X; Zhang X
    PLoS One; 2016; 11(1):e0146993. PubMed ID: 26785251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration.
    Chen XD; Li C; Ding GL; Suo Y; Zhu YS; Lu HQ
    Int J Ophthalmol; 2023; 16(9):1489-1495. PubMed ID: 37724264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy.
    Hu Z; Cao X; Chen L; Su Y; Ji J; Yuan S; Fransisca S; Mugisha A; Zou W; Xie P; Liu Q
    Acta Ophthalmol; 2022 May; 100(3):e726-e736. PubMed ID: 34260829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy assisted by intravitreal injection of conbercept enhances the therapeutic effect and quality of life in patients with severe proliferative diabetic retinopathy.
    Wang Q; Cai H; Xu D; Cui L; Zhang Y; Chen M
    Am J Transl Res; 2022; 14(2):1324-1331. PubMed ID: 35273734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Serum Concentrations of Vascular Endothelial Growth Factors-A and B after Intravitreal Injection of Ranibizumab and Conbercept for Retinopathy of Prematurity.
    Zhang H; Yang X; Zheng F; Wan S; Xu Y
    Ophthalmologica; 2023; 246(2):81-89. PubMed ID: 36709750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
    Jiang T; Gu J; Zhang P; Chen W; Chang Q
    BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.
    Ding Y; Su N; Luan J; Ni Y; Sun Z
    J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of RBP4 in the vitreous humour of patients with proliferative diabetic retinopathy who underwent Conbercept intravitreal injection.
    Wen D; Ren X; Li H; He Y; Hong Y; Cao J; Zheng C; Dong L; Li X
    Exp Eye Res; 2022 Dec; 225():109197. PubMed ID: 35932904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy.
    Yang Z; Di Y; Ye J; Yu W; Guo Z
    Front Endocrinol (Lausanne); 2023; 14():1171628. PubMed ID: 37305048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
    Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
    Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.